Find out which biopharma companies are raking in cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
Immunotherapies are about to get safer, more effective, and even more accessible with the new biotech’s novel approach.
The first Covid-19 vaccine is heading to regulators. Pfizer and BioNTech announced Friday morning that they would ask today for the FDA to issue an emergency use authorization for their ...
→ Jennifer Ziolkowski has decided to step down from Ilan Ganot’s team at Solid Biosciences “to pursue a new career opportunity,” according to an SEC document filed Friday. Ziolkowski will ...
Creating a path to treatment for chromosome 8p disorders through research, community, and intelligent information
Pfizer and BioNTech have done the final efficacy analysis for their Phase III Covid-19 trial, and the results confirm the headline-grabbing release from last week: Their vaccine is 95% ...
Venture capital firm SR One, founded in 1985 as the venture capital arm of pharma giant GlaxoSmithKline, completed its spinout from its parent company and closed its first independent fun ...
TEMPLE, Texas, Nov. 23, 2020 /PRNewswire/ -- Baylor Scott & White Health, the largest not-for-profit health system in the state of Texas, announced plans to partner with Baylor College ...